Targeting NLRP3 (nucleotide-binding domain, leucine- rich-containing family, pyrin domain-containing-3) inflammasome in cardiovascular disorders

61Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Inflammation is an important innate immune response to infection or tissue damage. Inflammasomes are involved in the onset and development of inflammation. The NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome is the best-characterized inflammasome. Recent evidence has indicated the importance of the NLRP3 inflammasome in the pathophysiology of cardiovascular disorders. To further understand the roles of the NLRP3 inflammasome in the cardiovascular system, we provide a comprehensive overview and discuss the remaining questions. First, a summary of NLRP3 inflammasome in the cardiovascular system is introduced. Then, the associations between NLRP3 inflammasome and cardiovascular disorders are presented. Finally, we discuss existing problems and potential directions with this issue. The information compiled here summarizes recent progress, thus potentially aiding in the understanding of the NLRP3 inflammasome in cardiovascular disorders, designing experimental and clinical research about the NLRP3 inflammasome, and promoting therapeutics for cardiovascular disorders.

Cite

CITATION STYLE

APA

Wang, Z., Hu, W., Lu, C., Ma, Z., Jiang, S., Gu, C., … Yang, Y. (2018). Targeting NLRP3 (nucleotide-binding domain, leucine- rich-containing family, pyrin domain-containing-3) inflammasome in cardiovascular disorders. Arteriosclerosis, Thrombosis, and Vascular Biology. Lippincott Williams and Wilkins. https://doi.org/10.1161/ATVBAHA.118.311916

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free